secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2022-03-03T23:59:59+00:00
Accession:  0000950142-22-000881
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Deepa Prasad resigns effective March 29, 2022; Richard Nelson appointed Interim CEO
--------------------------------------------------------------------------------

- Prasad resigns as CEO/President/Board member, will serve as Strategic Advisor for 6 months.
- Prasad receives $325,000 bonus, salary continuation for 15 months, retains 624,659 options.
- Richard Nelson appointed Acting CEO until March 29 then Interim CEO; enters employment agreement.
- Nelson to receive $200k base salary, 100% cash bonus for FY2022, options for 500,000 shares at $0.8060.
- Board amended bylaws to allow appointment of Lead Independent Director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000095014222000881/0000950142-22-000881-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000095014222000881/eh220231317_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950142-22-000881

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer